Neovasc Comments on European Heart Journal Publication
18. November 2022 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Nov. 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that European Heart Journal - Case...
Neovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory Angina
15. September 2022 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Sept. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today commented on the Centers for Medicare and...
Neovasc Announces Key Events at TCT 2022
08. September 2022 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, Sept. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced its participation and presence at the...
Neovasc Comments on EuroIntervention Article
19. April 2021 09:05 ET
|
Neovasc, Inc.
VANCOUVER and MINNEAPOLIS, April 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN) today announced that the journal EuroIntervention has...
Neovasc Named Finalist in Questex’s Fierce Innovation Awards LifeSciences Edition 2019
04. Dezember 2019 09:38 ET
|
Neovasc, Inc.
VANCOUVER, Dec. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN): NVCN), a leader in the development of minimally invasive...